Device Orthopedic Surgery

Linvatec Hip Preservation System

Payments companies reported to CMS as associated with Linvatec Hip Preservation System. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.

$50Kassociated payments (2023-2025)
37clinicians with associated payments
1company reporting

By year

2023 $5,870
2024 $26K
2025 $18K

Payments reported as associated with Linvatec Hip Preservation System, per program year, as reported to CMS.

Who makes it

Specialties most often involved

Sports Medicine (Orthopaedic Surgery) $43K
Orthopaedic Surgery $5,742
Physician Assistant $354
Adult Reconstructive Orthopaedic Surgery $56.52

Where the associated payments went, by the receiving clinician's specialty.

Clinicians most associated with Linvatec Hip Preservation System

These are the largest totals companies reported as associated with Linvatec Hip Preservation System. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.

ClinicianLocationSpecialtyAssociated payments (2023-2025)
Thomas Wuerz Waltham, MA Sports Medicine (Orthopaedic Surgery) $14,794.62
Carlos Guanche Tarzana, CA Sports Medicine (Orthopaedic Surgery) $11,510.71
Orr Limpisvasti Los Angeles, CA Sports Medicine (Orthopaedic Surgery) $9,542.54
Jovan Laskovski Akron, OH Sports Medicine (Orthopaedic Surgery) $6,362.32
Derek Ochiai Sterling, VA Orthopaedic Surgery $1,959.21
Robert Westermann Iowa City, IA Orthopaedic Surgery $1,528.43
William Robertson Arlington, TX Orthopaedic Surgery $1,134.23
Dhanur Damodar Seattle, WA Orthopaedic Surgery $210.10
Delbert Remaley Tampa, FL Orthopaedic Surgery $168.44
Victoria Allman Temple Terrace, FL Physician Assistant $168.44

Prescribed Linvatec Hip Preservation System?

See what its makers reported for your doctor. Two steps, private, no account.

Check my doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.